Global Tumor Ablation Market

Tumor Ablation Market Size, Share, Growth Analysis, By Technology(Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation), By Treatment(Surgical Ablation, Laparoscopic Ablation, and Percutaneous Ablation), By Application(Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer), By Product Type(Generators, and Probes/electrodes (Radiofrequency Ablation Probes, Microwave Ablation Probes and Other Probes/Electrodes)), By End Use(Hospitals & Clinics, Cancer Care Centers, Other End Users), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35A2494 | Region: Global | Published Date: September, 2024
Pages: 219 | Tables: 95 | Figures: 76

Tumor Ablation Market Competitive Landscape

Key companies are increasing their expenditure on R&D to produce minimally invasive and new tumor ablative therapies in order to gain a huge market share. For example, Boston Scientific Corporation got Health Canada certification in 2021 for its advanced freezing system, ICEfxTM. The device has a lower footprint, is portable, and offers a potent alternative to current cryoablation systems.

In order to maintain their market position, industry participants have implemented a variety of strategic activities such as new product launches, alliances, mergers, and acquisitions.

Top Player’s Company Profiles in Tumor Ablation Market

  • Medtronic plc (Ireland) 
  • Boston Scientific Corporation (US) 
  • Johnson & Johnson (Ethicon, Inc.) (US) 
  • AngioDynamics, Inc. (US) 
  • EDAP TMS S.A. (France) 
  • SonaCare Medical, LLC (US) 
  • Merit Medical Systems, Inc. (US) 
  • Misonix, Inc. (US) 
  • HealthTronics, Inc. (US) 
  • Galil Medical Ltd. (US) 
  • IceCure Medical Ltd. (Israel) 
  • Monteris Medical, Inc. (Canada) 
  • Hologic, Inc. (US) 
  • Symple Surgical Inc. (US) 
  • BVM Medical Limited (UK) 
  • Ablatherm (Esaote S.p.A.) (Italy) 
  • Bioventus LLC (US) 
  • CEVOTEC (Germany) 
  • Fujifilm Holdings Corporation (Japan) 
  • InSightec Ltd. (Israel) 
  • Philips Healthcare (Netherlands)

Tumor Ablation Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Tumor Ablation Market size was valued at USD 1.48 Billion in 2022 and is poised to grow from USD 1.68 Billion in 2023 to USD 4.63 Billion by 2031, by rising at a CAGR 13.5% during the forecast period (2024-2031).

Key companies are increasing their expenditure on R&D to produce minimally invasive and new tumor ablative therapies in order to gain a huge market share. For example, Boston Scientific Corporation got Health Canada certification in 2021 for its advanced freezing system, ICEfxTM. The device has a lower footprint, is portable, and offers a potent alternative to current cryoablation systems. 'Medtronic plc (Ireland) ', 'Boston Scientific Corporation (US) ', 'Johnson & Johnson (Ethicon, Inc.) (US) ', 'AngioDynamics, Inc. (US) ', 'EDAP TMS S.A. (France) ', 'SonaCare Medical, LLC (US) ', 'Merit Medical Systems, Inc. (US) ', 'Misonix, Inc. (US) ', 'HealthTronics, Inc. (US) ', 'Galil Medical Ltd. (US) ', 'IceCure Medical Ltd. (Israel) ', 'Monteris Medical, Inc. (Canada) ', 'Hologic, Inc. (US) ', 'Symple Surgical Inc. (US) ', 'BVM Medical Limited (UK) ', 'Ablatherm (Esaote S.p.A.) (Italy) ', 'Bioventus LLC (US) ', 'CEVOTEC (Germany) ', 'Fujifilm Holdings Corporation (Japan) ', 'InSightec Ltd. (Israel) ', 'Philips Healthcare (Netherlands)'

The rising prevalence of cancer globally, particularly in lung, liver, kidney, and breast cancers, is a major driver for the tumor ablation market. Tumor ablation techniques offer minimally invasive alternatives to surgery for the treatment of localized tumors, providing effective therapeutic options to patients who may not be suitable candidates for surgery.

Technological Advancements: The tumor ablation market is witnessing continuous technological advancements, leading to the development of more advanced and precise ablation techniques. These advancements include the integration of imaging modalities for real-time guidance, the use of robotic systems for improved accuracy, and the development of new energy sources for ablation. These technological advancements enhance the efficacy and safety of tumor ablation procedures.

In 2023, North America held a dominant revenue share of 34.42% in the market. The government's support of high-quality healthcare, the region's high purchasing power parity, the accessibility of reimbursements, and the rising incidence of cancer are major drivers of growth. For example, the Patient Protection and Affordable Care Act (PPACA) in the United States encourages access to high-quality, reasonably priced healthcare by lowering the cost of healthcare for both individuals and the government through health coverage programmed. Furthermore, the precision medicine movement involves developing customized approaches based on distinct features of illnesses. Therefore, it is projected that these government actions will enhance the healthcare system, driving market expansion. In 2023, Europe had a sizable portion. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Oncology Ablation Market
Buy Now GET FREE SAMPLE
Cardiac Ablation Market
Buy Now GET FREE SAMPLE
Ablation Devices Market
Buy Now GET FREE SAMPLE
MRI-Guided Neurosurgical Ablation Market
Buy Now GET FREE SAMPLE
Endometrial Ablation Market
Buy Now GET FREE SAMPLE
Cancer Pain Market
Buy Now GET FREE SAMPLE
Breast Cancer Market
Buy Now GET FREE SAMPLE
Cancer Biological Therapy Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Tumor Ablation Market

Report ID: SQMIG35A2494

$5,300
BUY NOW GET FREE SAMPLE